Beam Therapeutics Inc.BEAMNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-5.54%
↑ 68% above average
Average (30q)
-17.17%
Historical baseline
Range
High:222.71%
Low:-391.12%
Volatility
-3574.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -5.54% |
| Q2 2025 | -0.73% |
| Q1 2025 | -19.24% |
| Q4 2024 | 6.07% |
| Q3 2024 | -1.53% |
| Q2 2024 | -0.73% |
| Q1 2024 | -178.38% |
| Q4 2023 | 222.71% |
| Q3 2023 | -5.99% |
| Q2 2023 | -3.25% |
| Q1 2023 | -11.17% |
| Q4 2022 | 2.54% |
| Q3 2022 | -11.39% |
| Q2 2022 | -7.53% |
| Q1 2022 | -20.07% |
| Q4 2021 | 8.83% |
| Q3 2021 | -18.08% |
| Q2 2021 | 70.57% |
| Q1 2021 | -391.12% |
| Q4 2020 | -9.32% |
| Q3 2020 | -41.99% |
| Q2 2020 | 7.30% |
| Q1 2020 | -7.52% |
| Q4 2019 | -46.31% |
| Q3 2019 | -2.11% |
| Q2 2019 | -34.66% |
| Q1 2019 | 3.35% |
| Q4 2018 | -6.90% |
| Q3 2018 | -30.20% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |